Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar;114(3):280-283.
doi: 10.2105/AJPH.2023.307559.

Looking Back on COVID-19 and the Evolving Drug Overdose Crisis: Updated Trends Through 2022

Joseph Friedman  1
Affiliations
Editorial

Looking Back on COVID-19 and the Evolving Drug Overdose Crisis: Updated Trends Through 2022

Joseph Friedman. Am J Public Health. 2024 Mar.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1—
FIGURE 1—
Monthly Overdose Deaths: United States, January 2014–December 2022 Note. One trend line is shown per year, indicated by color. The legend shows the color corresponding to each year, as well as the annual total number of deaths for that year. All values from the year 2022 are provisional and may be revised to a minor degree in subsequently released final values. Drug overdose deaths were defined using the International Classification of Diseases, 10th Revision (Geneva, Switzerland: World Health Organization; 1992) codes for underlying cause of death, including unintentional, suicide, homicide, or undetermined intent (X40–44, X60–64, X85, or Y10–14, respectively). All data can be accessed publicly at wonder.cdc.gov. This figure highlights rising counts from year to year, as well as a sharp spike in deaths during the initial months of the COVID-19 pandemic in 2020.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Friedman J , Akre S. COVID-19 and the drug overdose crisis: uncovering the deadliest months in the United States, January‒July 2020. Am J Public Health. 2021;111(7):1284‒1291. 10.2105/AJPH.2021.306256 - DOI - PMC - PubMed
    1. Schneider KE , Allen ST , Rouhani S , et al. Increased solitary drug use during COVID-19: an unintended consequence of social distancing. Int J Drug Policy. 2023;111:103923. 10.1016/j.drugpo.2022.103923 - DOI - PMC - PubMed
    1. Tanz LJ , Dinwiddie AT , Snodgrass S , O’Donnell J , Mattson CL. A qualitative assessment of circumstances surrounding drug overdose deaths during early stages of the COVID-19 pandemic. SUDORS Data Brief. August 2022. Available at: https://www.cdc.gov/drugoverdose/databriefs/sudors-2.html. Accessed September 1, 2023.
    1. Aronowitz SV , Carroll JJ , Hansen H , et al. Substance use policy and practice in the COVID-19 pandemic: learning from early pandemic responses through internationally comparative field data. Glob Public Health. 2022;7(12): 3654‒3669. 10.1080/17441692.2022.2129720 - DOI - PubMed
    1. Ali F , Russell C , Nafeh F , Rehm J , LeBlanc S , Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237. 10.1016/j.drugpo.2021.103237 - DOI - PMC - PubMed

Substances